• Oncology
  • Current

Tizona Therapeutics, Inc. is a preclinical stage biotechnology company that is developing multiple, innovative immuno-oncology and autoimmune therapies. Tizona Therapeutics, Inc. was founded by MPM Capital and leading scientists from Dana Farber, the University of Pittsburgh and Yale.

tizonatx.com